Solomon Islands

Located in Melanesia, The Solomon Islands become a signatory of the APLMA roadmap in 2018.  

‍

The Solomon Islands currently accounts for 24% of the total malaria burden in the Asia Pacific region. The burden of malaria is variable; four provinces contribute approximately 75% of the malaria burden in the country in 2022. Those provinces are Central Islands (10%), Guadalcanal (26%), Honiara (12%), and Malaita (27%). Since 2015, the API has increased to 130 per thousand in 2022, as compared to just 30 per thousand in 2014. The resurgence in 2015 has been an unprecedented barrier to the country’s aim of elimination by 2030 at the time.  

‍

Their current malaria elimination strategy focuses on enhancing and optimising vector control and case management diagnosis and treatment. In doing so, they hope to reduce morbidity and mortality while reducing the parasite burden, reducing transmission. Together with innovation and research, surveillance is used to optimise programme outcomes, while creating an enabling environment for its impact.

‍

Currently among the countries making up 99% of the Asia Pacific’s malaria burden, the Solomon Islands aims to eliminate malaria by 2035.